PMSC-VENLAFAXINE XR

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 3e10491939c23ec1
Drug Approval Canada Name: PMSC-VENLAFAXINE XR
Product Name: PMSC-VENLAFAXINE XR
Status: Marketed
Status Date: 2022-09-23
Original Market Date: 2022-09-23
Din: 02521466
Drug Class: Human
Dosage Form: Capsule (Extended Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX16 VENLAFAXINE
Atc Name: n 06 ax 16
Aig Number: 0131294002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE)

37.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3e10491939c23ec1

Type

Standard